Vaughn Bryan T sold LH

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0000920148-26-000228

Machine-readable

Structured copy

Timestamps

Event (reported)

Nov 3, 2026

Published

Nov 5, 2026

Ingested by INSIDER

Nov 5, 13:26 UTC

Last re-read

Nov 5, 21:23 UTC

Extracted facts

Filer

Vaughn Bryan T

Role

EVP and President, Diagnostics

Transaction

Open-market saleAs filed: “S”

Asset

LABCORP HOLDINGS INC.

Ticker

LH

Shares

306

Price per share

$353.7

Value

$108,232

Execution date (reported)

Nov 3, 2026

Owned after transaction

6,845 shares

Rule 10b5-1 plan

Yes, as checked by the filer

Days from execution to publication

2

Calculation

What this establishes

Vaughn Bryan T filed this Form 4 reporting a open-market sale of LH on Nov 3, 2026. It became public on Nov 5, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

EVP and President, Diagnostics

Vaughn Bryan Tcik:0002103999

Issuer

LABCORP HOLDINGS INC.cik:0000920148

Revision history · 0

No field has changed since this record was first ingested.